Il-1β blockade

Il-1β blockade has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 3, 2026: “Blood-cell gene loss impairs heart recovery in mice”.

Intervention

1 paper studies it1 findingUpdated

1 new paper in 30 daysSee all 1

  • 1 lab
  • Animals1

What did studies of il-1β blockade find?

1

Studies of il-1β blockade measured 1 outcome; the most studied are adverse cardiac phenotype (1 study).

Adverse cardiac phenotype

downin mice1

1 study
  1. Il-1β blockade decreases adverse cardiac phenotype in mice after myocardial infarction with hematopoietic KDM6A loss.

    “IL-1β blockade after MI rescued the adverse cardiac phenotype of hematopoietic KDM6A loss.”

    Animalsafter myocardial infarction with hematopoietic KDM6A lossheart

    Blood-cell gene loss impairs heart recovery in mice

    Nature cardiovascular research

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Nature Cardiovascular Research

Blood-cell gene loss impairs heart recovery in mice

In mouse experiments, blocking an immune signal counteracted the harmful heart effects of losing KDM6A in blood-forming cells.In mouse experiments, blocking an immune signal counteracted the harmful heart effects of losing KDM6A in blood-forming cells.

Mouse studyMechanisms